PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells
- PMID: 20197384
- DOI: 10.1158/1541-7786.MCR-09-0368
PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells
Abstract
Deregulated PAX5 expression has been associated with metastatic mammary carcinoma, although the precise role of PAX5 in cancer progression is unclear. Stable forced expression of PAX5alpha in the mammary carcinoma cell lines MCF-7 and MDA-MB-231 reduced cell cycle progression, cell survival, and anchorage-independent cell growth. In xenograft studies, forced expression of PAX5alpha was associated with a significant reduction in tumor volume. Furthermore, forced expression of PAX5alpha in mammary carcinoma cells resulted in altered cell morphology with resultant enhancement of epithelial cell characteristics. Morphologic changes were associated with localization of beta-CATENIN at cell-cell junctions and with altered mRNA expression of mesenchymal markers in mammary carcinoma cells. In addition, forced expression of PAX5alpha in MCF-7 and MDA-MB-231 cells significantly reduced cell migration and invasion. Concomitantly, small interfering RNA-mediated depletion of PAX5alpha increased MCF-7 total cell number, cell motility, migration, and invasion. These studies show that PAX5alpha enhances the epithelial characteristics of mammary carcinoma cells, reminiscent of mesenchymal to epithelial transition.
Similar articles
-
Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells.Endocrinology. 2009 Oct;150(10):4473-83. doi: 10.1210/en.2009-0066. Epub 2009 Jul 9. Endocrinology. 2009. PMID: 19589871
-
Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.Endocrinology. 2010 Jan;151(1):43-55. doi: 10.1210/en.2009-0651. Epub 2009 Dec 4. Endocrinology. 2010. PMID: 19966185
-
Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.Biol Cell. 2010 Jan 6;102(3):159-72. doi: 10.1042/BC20090132. Biol Cell. 2010. PMID: 19895368
-
[Epithelial-mesenchymal transition and breast pathology].Ann Pathol. 2009 Nov;29 Spec No 1:S61-2. doi: 10.1016/j.annpat.2009.07.039. Epub 2009 Oct 7. Ann Pathol. 2009. PMID: 19887254 Review. French. No abstract available.
-
Coordinated expression of Pax-5 and FAK1 in metastasis.Anticancer Agents Med Chem. 2011 Sep;11(7):643-9. doi: 10.2174/187152011796817637. Anticancer Agents Med Chem. 2011. PMID: 21707507 Review.
Cited by
-
Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.Int J Biol Sci. 2018 Sep 7;14(12):1686-1695. doi: 10.7150/ijbs.27599. eCollection 2018. Int J Biol Sci. 2018. PMID: 30416383 Free PMC article.
-
Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.J Mammary Gland Biol Neoplasia. 2018 Sep;23(3):177-187. doi: 10.1007/s10911-018-9404-4. Epub 2018 Jul 21. J Mammary Gland Biol Neoplasia. 2018. PMID: 30032344
-
Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways.J Cancer. 2016 Oct 22;7(14):2035-2044. doi: 10.7150/jca.15200. eCollection 2016. J Cancer. 2016. PMID: 28070224 Free PMC article.
-
A tapered channel microfluidic device for comprehensive cell adhesion analysis, using measurements of detachment kinetics and shear stress-dependent motion.Biomicrofluidics. 2012 Mar;6(1):14107-1410712. doi: 10.1063/1.3673802. Epub 2012 Jan 31. Biomicrofluidics. 2012. PMID: 22355300 Free PMC article.
-
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.Oncotarget. 2017 Feb 14;8(7):12052-12066. doi: 10.18632/oncotarget.14511. Oncotarget. 2017. PMID: 28076843 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous